These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

108 related articles for article (PubMed ID: 21178136)

  • 21. Health economics of medical devices: opportunities and challenges.
    Simoens S
    J Med Econ; 2008; 11(4):713-7. PubMed ID: 19450077
    [TBL] [Abstract][Full Text] [Related]  

  • 22. An outline for public registration of clinical trials evaluating medical devices.
    Popp RL; Lorell BH; Stone GW; Laskey W; Smith JJ; Kaplan AV
    J Am Coll Cardiol; 2006 Apr; 47(8):1518-21. PubMed ID: 16630985
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Knowledge translation in tri-sectoral collaborations: An exploration of perceptions of academia, industry and healthcare collaborations in innovation adoption.
    Ii SS; Fitzgerald L; Morys-Carter MM; Davie NL; Barker R
    Health Policy; 2018 Feb; 122(2):175-183. PubMed ID: 29191387
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Innovating in the medical device industry - challenges & opportunities ESB 2015 translational research symposium.
    Bayon Y; Bohner M; Eglin D; Procter P; Richards RG; Weber J; Zeugolis DI
    J Mater Sci Mater Med; 2016 Sep; 27(9):144. PubMed ID: 27552808
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Developing an equivalent to the National Medicines Policy for medical devices.
    Smith MW; Faunce TA
    J Law Med; 2009 Dec; 17(3):412-25. PubMed ID: 20169801
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Role of the industry sponsor: protection of human subjects in early device-application studies.
    Oleson KA
    J Lab Clin Med; 2005 Jan; 145(1):17-20. PubMed ID: 15668657
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Better infrastructure: industry-academia partnerships--a marriage of convenience?
    Abraham E
    Crit Care Med; 2009 Jan; 37(1 Suppl):S159-64. PubMed ID: 19104217
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The changing environment for technological innovation in health care.
    Goodman CS; Gelijns AC
    Baxter Health Policy Rev; 1996; 2():267-315. PubMed ID: 11066263
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Brief of the Canadian Society for Clinical Investigation to the science and technology review.
    Clin Invest Med; 1995 Feb; 18(1):80-90. PubMed ID: 7768069
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Statistical and regulatory issues in nonrandomized medical device clinical studies.
    Li H; Yue LQ
    J Biopharm Stat; 2008; 18(1):20-30. PubMed ID: 18161539
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The NCI All Ireland Cancer Conference.
    Johnston PG; Daly PA; Liu E
    Oncologist; 1999; 4(4):275-277. PubMed ID: 10545862
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The impact of regulation.
    Magazine AH
    Med Device Technol; 1997 Mar; 8(2):38-44, 46, 48. PubMed ID: 10166366
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Developing a compliant approach to industry support for research and education in a climate of scrutiny.
    Kannensohn KJ; Soldato D; Carnell H
    Health Care Law Mon; 2010 Feb; 2010(2):2-7. PubMed ID: 20175336
    [No Abstract]   [Full Text] [Related]  

  • 34. Innovation in biotechnology: moving from academic research to product development--the case of biosensors.
    Siontorou CG; Batzias FA
    Crit Rev Biotechnol; 2010 Jun; 30(2):79-98. PubMed ID: 20214418
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Social Network Analysis in the Legislative Process in the Korean Medical Device Industry.
    Lee M; Yoon K; Lee KS
    Inquiry; 2018; 55():46958018791858. PubMed ID: 30132349
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Computerized medical device tracking--ways to comply with SMDA (Safe Medical Devices Act of 1990).
    Landis D
    Healthc Inform; 1992 Jul; 9(7):36, 38, 40-2. PubMed ID: 10119858
    [No Abstract]   [Full Text] [Related]  

  • 37. [Regulatory science forum--its background and goal].
    Uchiyama M
    Eisei Shikenjo Hokoku; 1993; (111):140-1. PubMed ID: 7920557
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Medical doctors driving technological innovation: questions about and innovation management approaches to incentive structures for lead users].
    Bohnet-Joschko S; Kientzler F
    Z Evid Fortbild Qual Gesundhwes; 2010; 104(10):721-6. PubMed ID: 21147434
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The Human Genome Project in the United States: a perspective on the commercial, ethical, legislative and health care issues.
    Mackler BF; Barach M
    J Int Bioethique; 1991; 2(3):149-57. PubMed ID: 11654898
    [TBL] [Abstract][Full Text] [Related]  

  • 40. OTA issues report on medical device policy.
    Humm M
    Pathologist; 1985 Feb; 39(2):62-3. PubMed ID: 10270449
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.